Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor.
Shimizu K, Fujikura H, Fushimi N, Nishimura T, Tatani K, Katsuno K, Fujimori Y, Watanabe S, Hiratochi M, Nakabayashi T, Kamada N, Arakawa K, Hikawa H, Azumaya I, Isaji M.
Shimizu K, et al. Among authors: fushimi n.
Bioorg Med Chem. 2021 Mar 15;34:116033. doi: 10.1016/j.bmc.2021.116033. Epub 2021 Jan 22.
Bioorg Med Chem. 2021.
PMID: 33581390